Skip to content

SKINOVATION PHARMACEUTICAL INCORPORATED

CIK 0001118072

← back to feed
Revenue (TTM)
$40.98K
0.0% YoY Q3 Nov 2024
Net Income (TTM)
−$43.99K
−6.3% YoY Q3 Nov 2024
EPS Diluted (TTM)
—
Q3 Nov 2024
Gross Margin
—
Q3 Nov 2024
Operating Margin
-53.2%
Q3 Nov 2024
Net Margin
-107.3%
Q3 Nov 2024
Free Cash Flow (TTM)
−$19.79K
Q3 Nov 2024
Cash
$1.84K
Q3 Nov 2024
Total Debt
—
Q3 Nov 2024
Shares Outstanding
708K sh
Q3 Nov 2024

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings